Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx - Related Studies

Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

This study is ongoing, but not recruiting participants.

Study NCT00004227. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Squamous Cell
		Head and Neck Neoplasms
		Oropharyngeal Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplasms, Squamous Cell
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Pharyngeal Diseases
		Pharyngeal Neoplasms
		Stomatognathic Diseases

4	Interventions listed in this trial
		cetuximab
		conventional surgery
		radiation therapy

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
		National Cancer Institute (NCI)